2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: Implant and follow-up recommendations and management

Jean Claude Daubert; Leslie Saxon; Philip B. Adamson; Angelo Auricchio; Ronald D. Berger; John F. Beshai; Ole Breithard; Michele Brignole; John Cleland; David B. Delurgio; Kenneth Dickstein; Derek V. Exner; Michael Gold; Richard A. Grimm; David L. Hayes; Carsten Israel; Christophe Leclercq; Cecilia Linde; Joann Lindenfeld; Bela Merkely; Lluis Mont; Francis Murgatroyd; Frits Prinzen; Samir F. Saba; Jerold S. Shinbane; Jagmeet Singh; Anthony S. Tang; Panos E. Vardas; Bruce L. Wilkoff; Jose Luis Zamorano; Inder Anand; Carina Blomström-Lundqvist; John P. Boehmer; Hugh Calkins; Serge Cazeau; Victoria Delgado; N. A.Mark Estes; David Haines; Fred Kusumoto; Paco Leyva; Frank Ruschitzka; Lynne Warner Stevenson; Christian Tobias Torp-Pedersen

doi:10.1093/europace/eus222

2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: Implant and follow-up recommendations and management

Jean Claude Daubert, Leslie Saxon, Philip B. Adamson, Angelo Auricchio, Ronald D. Berger, John F. Beshai, Ole Breithard, Michele Brignole, John Cleland, David B. Delurgio, Kenneth Dickstein, Derek V. Exner, Michael Gold, Richard A. Grimm, David L. Hayes, Carsten Israel, Christophe Leclercq, Cecilia Linde, Joann Lindenfeld, Bela MerkelyLluis Mont, Francis Murgatroyd, Frits Prinzen, Samir F. Saba, Jerold S. Shinbane, Jagmeet Singh, Anthony S. Tang, Panos E. Vardas, Bruce L. Wilkoff, Jose Luis Zamorano, Inder Anand, Carina Blomström-Lundqvist, John P. Boehmer, Hugh Calkins, Serge Cazeau, Victoria Delgado, N. A.Mark Estes, David Haines, Fred Kusumoto, Paco Leyva, Frank Ruschitzka, Lynne Warner Stevenson, Christian Tobias Torp-Pedersen

School of Medicine

Research output: Contribution to journal › Article › peer-review

191 Scopus citations

Original language	English (US)
Pages (from-to)	1236-1286
Number of pages	51
Journal	Europace
Volume	14
Issue number	9
DOIs	https://doi.org/10.1093/europace/eus222
State	Published - Sep 2012

Keywords

CRT
Cardiac resynchronization therapy
Consensus recommendations
Follow-up
Non-responder

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine
Physiology (medical)

Access to Document

10.1093/europace/eus222

Cite this

Daubert, J. C., Saxon, L., Adamson, P. B., Auricchio, A., Berger, R. D., Beshai, J. F., Breithard, O., Brignole, M., Cleland, J., Delurgio, D. B., Dickstein, K., Exner, D. V., Gold, M., Grimm, R. A., Hayes, D. L., Israel, C., Leclercq, C., Linde, C., Lindenfeld, J., ... Torp-Pedersen, C. T. (2012). 2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: Implant and follow-up recommendations and management. Europace, 14(9), 1236-1286. https://doi.org/10.1093/europace/eus222

Daubert, JC, Saxon, L, Adamson, PB, Auricchio, A, Berger, RD, Beshai, JF, Breithard, O, Brignole, M, Cleland, J, Delurgio, DB, Dickstein, K, Exner, DV, Gold, M, Grimm, RA, Hayes, DL, Israel, C, Leclercq, C, Linde, C, Lindenfeld, J, Merkely, B, Mont, L, Murgatroyd, F, Prinzen, F, Saba, SF, Shinbane, JS, Singh, J, Tang, AS, Vardas, PE, Wilkoff, BL, Zamorano, JL, Anand, I, Blomström-Lundqvist, C, Boehmer, JP, Calkins, H, Cazeau, S, Delgado, V, Estes, NAM, Haines, D, Kusumoto, F, Leyva, P, Ruschitzka, F, Stevenson, LW & Torp-Pedersen, CT 2012, '2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: Implant and follow-up recommendations and management', Europace, vol. 14, no. 9, pp. 1236-1286. https://doi.org/10.1093/europace/eus222

@article{67802afd8bfc443aa38a57e33d707b64,

title = "2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: Implant and follow-up recommendations and management",

keywords = "CRT, Cardiac resynchronization therapy, Consensus recommendations, Follow-up, Non-responder",

author = "Daubert, {Jean Claude} and Leslie Saxon and Adamson, {Philip B.} and Angelo Auricchio and Berger, {Ronald D.} and Beshai, {John F.} and Ole Breithard and Michele Brignole and John Cleland and Delurgio, {David B.} and Kenneth Dickstein and Exner, {Derek V.} and Michael Gold and Grimm, {Richard A.} and Hayes, {David L.} and Carsten Israel and Christophe Leclercq and Cecilia Linde and Joann Lindenfeld and Bela Merkely and Lluis Mont and Francis Murgatroyd and Frits Prinzen and Saba, {Samir F.} and Shinbane, {Jerold S.} and Jagmeet Singh and Tang, {Anthony S.} and Vardas, {Panos E.} and Wilkoff, {Bruce L.} and Zamorano, {Jose Luis} and Inder Anand and Carina Blomstr{\"o}m-Lundqvist and Boehmer, {John P.} and Hugh Calkins and Serge Cazeau and Victoria Delgado and Estes, {N. A.Mark} and David Haines and Fred Kusumoto and Paco Leyva and Frank Ruschitzka and Stevenson, {Lynne Warner} and Torp-Pedersen, {Christian Tobias}",

note = "Funding Information: EHRA/HRS expert consensus statement on cardiac resynchronization therapy implant and follow-up considerations - document reviewers Expert Type of relationship with industry Anand Inder A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - CVRx : Carotid sinus stimulation device (2011) - Amgen : Darbepoetin (2011) - Boston Scientific : Devices (2011) - Sanofi Aventis : Donaderone (2011) - BMS : Irbesartan (2011) - Novartis : Pharmaceutical products (2011) - Cybertronics : Vagal stimulation device (2011) B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Amgen : Darbepoetin (2011) - Novartis : Heart Failure (2011) - NHLBI : Heart Failure Trials (2011) D - Research funding (departmental or institutional). - NHLBI : Heart Failure Clinical Trials (2011) Blomstrom-Lundqvist Carina A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Sanofi Aventis : AF (2011) B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Biotronik : Arrhythmia (2011) - Medtronic : ICD, AF (2011) D - Research funding (departmental or institutional). - Medtronic : AF (2011) - Atricure : AF (2011) - Biotronik : Arrhythmias (2011) Boehmer John A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Boston Scientific : CRT, ICD therapy (2011) B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Medtronic : CRT therapy, Events Committees (2011) C - Receipt of royalties for intellectual property. - St Jude Medical : Atrial fibrillation (2011) D - Research funding (departmental or institutional). - St Jude Medical : Hemodynamic monitoring (2011) Calkins Hugh E - Research funding (personal). - Medtronic : sudden death (2011) - St Jude Medical : sudden death (2011) Cazeau Serge A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Medtronic : CRM (2011) - Sorin Group : CRM (2011) Delgado Victoria A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - St Jude Medical : cardiac resynchronization therapy (2011) - Medtronic : Valvular heart disease (2011) Estes N A Mark A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Boston Scientific : Pacemakers/ICDs (2011) - Medtronic : Pacemakers/ ICDs (2011) D - Research funding (departmental or institutional). - Boston Scientific : Pacemakers/ ICDs Fellowship Support (2011) - Medtronic : Pacemakers/ICDs Fellowship Support (2011) - St Jude Medical : Pacemakers/ICDs Fellowship Support (2011) E - Research funding (personal). - Boston Scientific : Pacemakers/ICDs Fellowship Support (2011) Haines David B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Boston Scientific : catheter (2011) - Medtronic : catheter (2011) - Bard : catheter (2011) - Toray Medical : catheter (2011) - Zoll Medical : defibrillator (2011) D - Research funding (departmental or institutional). - CardioFocus : catheter (2011) - Medtronic : ICD (2011) Kusumoto Fred M None Leyva-Leon Francisco Leyva-Leon Francisco A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Boston Scientific : Cardiac devices (2011) - Medtronic : Cardiac devices (2011) - Sorin Group : Cardiac devices (2011) D - Research funding (departmental or institutional). - Medtronic : Cardiac devices (2011) - Sorin Group : Cardiac devices (2011) - St Jude Medical : Cardiac devices (2011) Ruschitzka Frank A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Biotronik : Devices (2011) B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Servier : Drugs (2011) C - Receipt of royalties for intellectual property. - Cardiorentis : Drugs (2011) D - Research funding (departmental or institutional). - Pfizer : Drugs (2011) Torp-Pedersen Christian Tobias A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Sanofi Aventis : Antiarrhythmics (2011) - Merck Sharp & Dohme : Antiarrhythmics, diabetes (2011) - Cardiomems : atrial fibrillation (2011) B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Sanofi Aventis : Investigator various drugs (2011) - Merck Sharp & Dohme : Investigator various drugs (2011) - Bristol Myers Squibb : Investigator, various drugs (2011) D - Research funding (departmental or institutional). - Bristol Meyer : Atrial fibrillation (2011) Warner Stevenson Lynne None ",

year = "2012",

month = sep,

doi = "10.1093/europace/eus222",

language = "English (US)",

volume = "14",

pages = "1236--1286",

journal = "Europace",

issn = "1099-5129",

publisher = "Oxford University Press",

number = "9",

}

TY - JOUR

T1 - 2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure

T2 - Implant and follow-up recommendations and management

AU - Daubert, Jean Claude

AU - Saxon, Leslie

AU - Adamson, Philip B.

AU - Auricchio, Angelo

AU - Berger, Ronald D.

AU - Beshai, John F.

AU - Breithard, Ole

AU - Brignole, Michele

AU - Cleland, John

AU - Delurgio, David B.

AU - Dickstein, Kenneth

AU - Exner, Derek V.

AU - Gold, Michael

AU - Grimm, Richard A.

AU - Hayes, David L.

AU - Israel, Carsten

AU - Leclercq, Christophe

AU - Linde, Cecilia

AU - Lindenfeld, Joann

AU - Merkely, Bela

AU - Mont, Lluis

AU - Murgatroyd, Francis

AU - Prinzen, Frits

AU - Saba, Samir F.

AU - Shinbane, Jerold S.

AU - Singh, Jagmeet

AU - Tang, Anthony S.

AU - Vardas, Panos E.

AU - Wilkoff, Bruce L.

AU - Zamorano, Jose Luis

AU - Anand, Inder

AU - Blomström-Lundqvist, Carina

AU - Boehmer, John P.

AU - Calkins, Hugh

AU - Cazeau, Serge

AU - Delgado, Victoria

AU - Estes, N. A.Mark

AU - Haines, David

AU - Kusumoto, Fred

AU - Leyva, Paco

AU - Ruschitzka, Frank

AU - Stevenson, Lynne Warner

AU - Torp-Pedersen, Christian Tobias

N1 - Funding Information: EHRA/HRS expert consensus statement on cardiac resynchronization therapy implant and follow-up considerations - document reviewers Expert Type of relationship with industry Anand Inder A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - CVRx : Carotid sinus stimulation device (2011) - Amgen : Darbepoetin (2011) - Boston Scientific : Devices (2011) - Sanofi Aventis : Donaderone (2011) - BMS : Irbesartan (2011) - Novartis : Pharmaceutical products (2011) - Cybertronics : Vagal stimulation device (2011) B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Amgen : Darbepoetin (2011) - Novartis : Heart Failure (2011) - NHLBI : Heart Failure Trials (2011) D - Research funding (departmental or institutional). - NHLBI : Heart Failure Clinical Trials (2011) Blomstrom-Lundqvist Carina A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Sanofi Aventis : AF (2011) B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Biotronik : Arrhythmia (2011) - Medtronic : ICD, AF (2011) D - Research funding (departmental or institutional). - Medtronic : AF (2011) - Atricure : AF (2011) - Biotronik : Arrhythmias (2011) Boehmer John A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Boston Scientific : CRT, ICD therapy (2011) B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Medtronic : CRT therapy, Events Committees (2011) C - Receipt of royalties for intellectual property. - St Jude Medical : Atrial fibrillation (2011) D - Research funding (departmental or institutional). - St Jude Medical : Hemodynamic monitoring (2011) Calkins Hugh E - Research funding (personal). - Medtronic : sudden death (2011) - St Jude Medical : sudden death (2011) Cazeau Serge A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Medtronic : CRM (2011) - Sorin Group : CRM (2011) Delgado Victoria A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - St Jude Medical : cardiac resynchronization therapy (2011) - Medtronic : Valvular heart disease (2011) Estes N A Mark A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Boston Scientific : Pacemakers/ICDs (2011) - Medtronic : Pacemakers/ ICDs (2011) D - Research funding (departmental or institutional). - Boston Scientific : Pacemakers/ ICDs Fellowship Support (2011) - Medtronic : Pacemakers/ICDs Fellowship Support (2011) - St Jude Medical : Pacemakers/ICDs Fellowship Support (2011) E - Research funding (personal). - Boston Scientific : Pacemakers/ICDs Fellowship Support (2011) Haines David B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Boston Scientific : catheter (2011) - Medtronic : catheter (2011) - Bard : catheter (2011) - Toray Medical : catheter (2011) - Zoll Medical : defibrillator (2011) D - Research funding (departmental or institutional). - CardioFocus : catheter (2011) - Medtronic : ICD (2011) Kusumoto Fred M None Leyva-Leon Francisco Leyva-Leon Francisco A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Boston Scientific : Cardiac devices (2011) - Medtronic : Cardiac devices (2011) - Sorin Group : Cardiac devices (2011) D - Research funding (departmental or institutional). - Medtronic : Cardiac devices (2011) - Sorin Group : Cardiac devices (2011) - St Jude Medical : Cardiac devices (2011) Ruschitzka Frank A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Biotronik : Devices (2011) B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Servier : Drugs (2011) C - Receipt of royalties for intellectual property. - Cardiorentis : Drugs (2011) D - Research funding (departmental or institutional). - Pfizer : Drugs (2011) Torp-Pedersen Christian Tobias A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Sanofi Aventis : Antiarrhythmics (2011) - Merck Sharp & Dohme : Antiarrhythmics, diabetes (2011) - Cardiomems : atrial fibrillation (2011) B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Sanofi Aventis : Investigator various drugs (2011) - Merck Sharp & Dohme : Investigator various drugs (2011) - Bristol Myers Squibb : Investigator, various drugs (2011) D - Research funding (departmental or institutional). - Bristol Meyer : Atrial fibrillation (2011) Warner Stevenson Lynne None

PY - 2012/9

Y1 - 2012/9

KW - CRT

KW - Cardiac resynchronization therapy

KW - Consensus recommendations

KW - Follow-up

KW - Non-responder

UR - http://www.scopus.com/inward/record.url?scp=84865785649&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865785649&partnerID=8YFLogxK

U2 - 10.1093/europace/eus222

DO - 10.1093/europace/eus222

M3 - Article

C2 - 22930717

AN - SCOPUS:84865785649

SN - 1099-5129

VL - 14

SP - 1236

EP - 1286

JO - Europace

JF - Europace

IS - 9

ER -

2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: Implant and follow-up recommendations and management

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this